Skip to main content

Designed for Canadian healthcare professionals

English
French
English

Stay Informed Opens in new tab
English
- English
- French
- English

English
French
English

Skip to main Content

Product Monograph Opens in new tab

Product Monograph

Home
Access SPEVIGO®
Mechanism of Action
Efficacy
Safety Profile
Safety Information
Dosing and Administration

References

SPEVIGO® Product Monograph, Boehringer Ingelheim (Canada) Ltd. March 22, 2023.
Data on file. Boehringer Ingelheim. March 22, 2023.

SPEVIGO

Terms of Use
Privacy Policy
Site Map
References
Product Monograph Opens in new tab

Accessibility: This website supports the dignity, independence, integration, and equal opportunity of people with disabilities and, as such, will comply with accessibility standards set out in the Accessibility for Ontarians with Disabilities Act, 2005 (AODA).

SPEVIGO® is a registered trademark of Boehringer Ingelheim International GmbH, used under license. © 2023 Boehringer Ingelheim (Canada) Ltd./Ltée. All rights reserved. Last updated: July 2023/PC-CA-103773